Recent evidence shows that IL-6R is overexpressed on CSCs and IL-6 secreted by both tumor cells and endothelial cells (ECs) enhances the survival, self-renewal and tumor initiation potential of cancer stem cells in HNSCC [8]. This evidence concerns the gene IL6 and cancer.